Concepedia

Duc‐Hiep Bach

DB

11

Publications

485

Citations

11

H-Index

2015

Active since

Affiliations

Seoul National University(Current)

Korea Research Institute of Bioscience and Biotechnology

The University of Texas MD Anderson Cancer Center

Shenyang Pharmaceutical University

Duc‐Hiep Bach is an author at Seoul National University specializing in medicine, cancer biology, and cancer research.

ORCID

Top concepts

Publications per year

2015–2022

11

Publications

11

AXL degradation in combination with EGFR-TKI can delay and overcome acquired resistance in human non-small cell lung cancer cells

Donghwa Kim, Duc‐Hiep Bach, Yanhua Fan et al. · Cell Death and Disease · 2019 · 98 citations · Full text

Targeting Nicotinamide N-Methyltransferase and miR-449a in EGFR-TKI-Resistant Non-Small-Cell Lung Cancer Cells

Duc‐Hiep Bach, Donghwa Kim, Song Yi Bae et al. · Molecular Therapy — Nucleic Acids · 2018 · 83 citations · Full text

BMP4 Upregulation Is Associated with Acquired Drug Resistance and Fatty Acid Metabolism in EGFR-Mutant Non-Small-Cell Lung Cancer Cells

Duc‐Hiep Bach, Thi-Thu-Trang Luu, Donghwa Kim et al. · Molecular Therapy — Nucleic Acids · 2018 · 53 citations · Full text

Synthesis and biological activity of new phthalimides as potential anti-inflammatory agents

Duc‐Hiep Bach, Jianyu Liu, Won Kyung Kim et al. · Bioorganic & Medicinal Chemistry · 2017 · 52 citations

, , +7

Naphthoquinone–Oxindole Alkaloids, Coprisidins A and B, from a Gut-Associated Bacterium in the Dung Beetle, <i>Copris tripartitus</i>

Soohyun Um, Duc‐Hiep Bach, Bora Shin et al. · Organic Letters · 2016 · 49 citations

Rows per page

1–5 of 11